Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 2.820
+0.030 (1.08%)
At close: Dec 24, 2025
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 505.17 million as of December 26, 2025. Its market cap has increased by 112.27% in one year.
Market Cap
505.17M
Enterprise Value
491.50M
Revenue
6.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.82
Market Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 505.17M, an increase of 3,897.47%. That is a compound annual growth rate of 47.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 505.17M | 115.41% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | 226.55M | 992.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.74B |
| Pro Medicus | 23.58B |
| Cochlear | 17.13B |
| Sonic Healthcare | 11.15B |
| Ramsay Health Care | 8.09B |
| Ansell | 5.05B |
| Telix Pharmaceuticals | 4.04B |
| Mesoblast | 3.69B |